The approval process involves several steps, beginning with the submission of a marketing authorization application by a pharmaceutical company. The CHMP then conducts a rigorous evaluation of the clinical trial data to assess the safety, efficacy, and quality of the medicinal product. This process often includes input from various experts in the field of gynecology to ensure that the specific needs of female patients are considered.
